Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis
出版年份 2016 全文链接
标题
Prognostic Value and Implication for Chemotherapy Treatment of ABCB1 in Epithelial Ovarian Cancer: A Meta-Analysis
作者
关键词
Ovarian cancer, Cancer chemotherapy, Meta-analysis, Prognosis, Histology, Cancer treatment, Platinum, Chemotherapy
出版物
PLoS One
Volume 11, Issue 11, Pages e0166058
出版商
Public Library of Science (PLoS)
发表日期
2016-11-04
DOI
10.1371/journal.pone.0166058
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Multidrug resistance-associated biomarkers PGP, GST-π, Topo-II and LRP as prognostic factors in primary ovarian carcinoma
- (2016) D. Lu et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Genetic polymorphisms and gene-dosage effect in ovarian cancer risk and response to paclitaxel/cisplatin chemotherapy
- (2015) Karolina Tecza et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma
- (2014) Koji Matsuo et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. A. Ledermann et al. ANNALS OF ONCOLOGY
- Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome
- (2013) K. L. White et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: A comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas
- (2013) Sharon E. Johnatty et al. GYNECOLOGIC ONCOLOGY
- Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum
- (2012) Ahmed Y. Ali et al. Annals of the New York Academy of Sciences
- Reversal of ATP-binding cassette drug transporter activity to modulate chemoresistance: why has it failed to provide clinical benefit?
- (2012) Man Yu et al. CANCER AND METASTASIS REVIEWS
- Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistancein vitroandin vivo
- (2012) Ke-Jun Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein
- (2012) Britta Stordal et al. PLoS One
- Improving Cancer Chemotherapy with Modulators of ABC Drug Transporters
- (2011) S. Shukla et al. CURRENT DRUG TARGETS
- Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer
- (2011) Troels K. Bergmann et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: A Gynecologic Oncology Group study
- (2011) Chunqiao Tian et al. GYNECOLOGIC ONCOLOGY
- Treatment-Related Protein Biomarker Expression Differs between Primary and Recurrent Ovarian Carcinomas
- (2011) D. A. Zajchowski et al. MOLECULAR CANCER THERAPEUTICS
- ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy
- (2008) S. E. Johnatty et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started